NewHold and newcleo file SEC registration for business combination
NewHold Investment Corp. III and newcleo Ltd. filed a Form F-4 registration statement with the SEC for their proposed business combination, expected to close in the second half of 2026. The deal aims to provide newcleo with up to $429 million in gross proceeds from PIPE and trust account funds, facilitating its AMR technology development. The combined company, newcleo plc, will seek a Nasdaq listing under the ticker NWCL, subject to shareholder and regulatory approvals.

*this image is generated using AI for illustrative purposes only.
NewHold Investment Corp. III and newcleo Ltd. announced the filing of a registration statement on Form F-4 with the U.S. Securities and Exchange Commission (SEC) on July 6, 2026, regarding their proposed business combination. The transaction is expected to deliver up to $429 million in gross proceeds to newcleo, funded through $220 million in private investment in public equity (PIPE) proceeds and up to $209 million held in the NewHold trust account. This capital injection is intended to support newcleo's development of advanced modular reactor (AMR) technology and nuclear fuel manufacturing, addressing industry challenges related to costs, safety, and waste management.
The business combination agreement, initially signed on May 27, 2026, has received approval from the Boards of Directors of both companies. Closing is anticipated in the second half of 2026, contingent upon NewHold shareholder approval, the SEC declaring the registration statement effective, and other customary closing conditions. Upon completion, the combined entity will operate as newcleo plc and is expected to trade on The Nasdaq Stock Market LLC under the symbol "NWCL".
Financial and Operational Details
The proposed merger structure outlines specific funding sources and operational goals for the combined entity. The following table details the expected gross proceeds:
| Source of Funds | Amount |
|---|---|
| PIPE Proceeds | $220 million |
| NewHold Trust Account | Up to $209 million |
| Total Gross Proceeds | Up to $429 million |
newcleo focuses on lead-cooled fast reactors (LFRs) utilizing mixed-oxide (MOX) fuel derived from reprocessed nuclear waste. Founded in 2021, the company reported over $80 million in revenue, other income, and financial income for 2024. It has secured over $780 million in private funding and employs more than 900 personnel across Europe and the United States.
Regulatory and Shareholder Considerations
The registration statement includes a preliminary proxy statement and prospectus, which remain subject to SEC review and modification before becoming effective. NewHold shareholders will receive definitive proxy statements regarding the extraordinary general meeting to vote on the proposed transactions. The SEC has not yet approved or disapproved the transaction, nor has it passed upon the merits or fairness of the deal.
NewHold Investment Corp. III is a special purpose acquisition company (SPAC) targeting industrial and business services sectors. Its leadership includes Kevin Charlton as Chief Executive Officer, Samy Hammad as President and Chief Operating Officer, and Polly Schneck as Chief Financial Officer. The solicitation of proxies from NewHold shareholders involves directors and executive officers from both NewHold and newcleo, with detailed information available in the proxy statement/prospectus.
How will newcleo allocate the $429 million in capital across its lead-cooled fast reactor development and nuclear fuel manufacturing divisions?
What specific regulatory approvals are required beyond the SEC declaration to operationalize newcleo's MOX fuel technology in the US and Europe?
How might the trading debut of NWCL on Nasdaq impact investor sentiment toward other advanced nuclear modular reactor companies?





















